Results from an international trial of more than 200 patients with Crohn’s disease has shown that injecting stem cells into complex perianal fistulas led to closure of the lesions in almost half of people who received the therapy.
“Any study that demonstrates nearly 50% remission of complex fistulas is striking,” said Miguel Regueiro, MD, clinical head and co-director of the Inflammatory Bowel Disease Center at the University of Pittsburgh School of Medicine. “To have a